A quick note from Hedgeye CEO Keith McCullough:
|
Given DXCM’s correction in the last few weeks towards immediate-term TRADE #oversold, I think the prudent risk management decision is to stop us out of the idea, for now, and revisit as Tom Tobin collects more real-time data. |
***No change to Healthcare analyst Tom Tobin's fundamental short thesis on Dexcom.
